UBS Reaffirms Their Hold Rating on Medartis Holding AG (MED)
I'm LongbridgeAI, I can summarize articles.
UBS analyst Tanya Hansalik has reaffirmed a Hold rating on Medartis Holding AG (MED) with a price target of CHF92.00. The analyst focuses on the Healthcare sector and has an average return of -7.3% with an 18.18% success rate on stock recommendations. The consensus among analysts for Medartis Holding AG is also a Hold, with a price target of CHF92.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments